Aequs Limited is set to launch its initial public offering on December 3, 2025, aiming to raise ₹921.81 crore to fund debt repayment and capital expenditure. The company, a leading precision engineering manufacturer specializing in aerospace and consumer durables, has fixed its price band at ₹118-₹124 per equity share. Market enthusiasts are actively tracking the IPO GMP, which currently stands at a robust ₹44.5, reflecting a premium of nearly 36% over the upper price band. This positive IPO GMP signals healthy appetite from investors, despite the company reporting a net loss in FY25.

Aequs operates a unique, vertically integrated manufacturing ecosystem in Belagavi, supplying critical components to global giants like Airbus and Boeing. This niche positioning in the aerospace supply chain is a key driver behind the optimistic IPO GMP figures. The IPO includes a fresh issue of ₹670 crore, which will help strengthen its balance sheet, alongside an Offer for Sale (OFS) by existing shareholders. While the IPO GMP offers a glimpse into potential listing gains, analysts advise looking at the company’s long-term order book and operational scale. With the allotment date slated for December 8 and listing on December 10, the grey market activity remains a crucial short-term indicator for retail and HNI investors assessing the listing pop potential.